Skip to content
10-Q

Quarterly Report

HUMAN GENOME SCIENCES INC

0001193125-12-316881

← back to feed
Filed
Jul 26, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Jun 30, 2012 199.99M sh
Capex Q2 2012 · Jun 30, 2012 $5.25M
Capex Q2 2012 · Jun 30, 2011 $7.49M
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$130.52M
Operating Cash Flow Q2 2012 · Jun 30, 2011 −$235.13M
Cash And Equivalents Q2 2012 · Jun 30, 2012 $349.96M
Cash And Equivalents Q2 2012 · Dec 31, 2011 $402.05M
Cash And Equivalents Q2 2012 · Jun 30, 2011 $53.69M
Cash And Equivalents Q2 2012 · Dec 31, 2010 $155.69M
Stockholders Equity Q2 2012 · Jun 30, 2012 $300.65M
Stockholders Equity Q2 2012 · Dec 31, 2011 $456.42M
Current Liabilities Q2 2012 · Jun 30, 2012 $331.73M
Current Liabilities Q2 2012 · Dec 31, 2011 $323.55M
Total Liabilities Q2 2012 · Jun 30, 2012 $975M
Total Liabilities Q2 2012 · Dec 31, 2011 $951.16M
Current Assets Q2 2012 · Jun 30, 2012 $594.16M
Current Assets Q2 2012 · Dec 31, 2011 $650.1M
Total Assets Q2 2012 · Jun 30, 2012 $1.28B
Total Assets Q2 2012 · Dec 31, 2011 $1.41B
Rd Expense Q2 2012 · Jun 30, 2012 $35.44M
Rd Expense Q2 2012 · Jun 30, 2012 $75.01M
Rd Expense Q2 2012 · Jun 30, 2011 $33.4M
Rd Expense Q2 2012 · Jun 30, 2011 $117.89M
Net Income Q2 2012 · Jun 30, 2012 −$92.8M
Net Income Q2 2012 · Jun 30, 2012 −$186.3M
Net Income Q2 2012 · Jun 30, 2011 −$80.66M
Net Income Q2 2012 · Jun 30, 2011 −$211.66M
Operating Income Q2 2012 · Jun 30, 2012 −$75.19M
Operating Income Q2 2012 · Jun 30, 2012 −$151.37M
Operating Income Q2 2012 · Jun 30, 2011 −$68.49M
Operating Income Q2 2012 · Jun 30, 2011 −$184.49M
Cost Of Revenue Q2 2012 · Jun 30, 2012 $7.88M
Cost Of Revenue Q2 2012 · Jun 30, 2012 $16.16M
Cost Of Revenue Q2 2012 · Jun 30, 2011 $11.61M
Cost Of Revenue Q2 2012 · Jun 30, 2011 $21.61M
Revenue Q2 2012 · Jun 30, 2012 $60.34M
Revenue Q2 2012 · Jun 30, 2012 $107.47M
Revenue Q2 2012 · Jun 30, 2011 $24.86M
Revenue Q2 2012 · Jun 30, 2011 $51.43M